Catalyst Wire Dossier Catalyst Wire Dossier

recombinant human papillomavirus 16/18 bivalent vaccine

HPV16/18 bivalent vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant human papillomavirus 16/18 bivalent vaccine, covering 2018-08-16 to 2018-08-16. Get the full timeline:

Most recent: Clinical Trial Update: A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls [Phase 3]

See pricing